• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine

Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine

9780323835862
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
398.11 zł
338.39 zł Save 59.72 zł Tax included
Lowest price within 30 days before promotion: 338.39 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Clinics in Laboratory Medicine, guest editors Drs. Daimon P. Simmons and Peter H. Schur bring their considerable expertise to the topic of Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19. Top experts in the field cover key topics such as performance of central lab assays to detect SARS-COV-2 antibodies; alternative methods to detect SARS-CoV-2 antibodies; the role of antibodies in developing vaccines for COVID-19; SARS-COV-2 antibodies after immunization; and more.
Product Details
Elsevier
92798
9780323835862
9780323835862

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
390
  • Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing - A Laboratory Primer
    Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
    Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
    Alternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies
    Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation
    Antibody Dynamics and Durability in Coronavirus Disease-19
    Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses
    Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)
Comments (0)